Cargando…
The Management of Orthostatic Hypotension in Parkinson’s Disease
Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson’s disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677136/ https://www.ncbi.nlm.nih.gov/pubmed/23772219 http://dx.doi.org/10.3389/fneur.2013.00064 |
_version_ | 1782272708920213504 |
---|---|
author | Sánchez-Ferro, Álvaro Benito-León, Julián Gómez-Esteban, Juan Carlos |
author_facet | Sánchez-Ferro, Álvaro Benito-León, Julián Gómez-Esteban, Juan Carlos |
author_sort | Sánchez-Ferro, Álvaro |
collection | PubMed |
description | Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson’s disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD. |
format | Online Article Text |
id | pubmed-3677136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-36771362013-06-14 The Management of Orthostatic Hypotension in Parkinson’s Disease Sánchez-Ferro, Álvaro Benito-León, Julián Gómez-Esteban, Juan Carlos Front Neurol Neuroscience Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson’s disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD. Frontiers Media S.A. 2013-06-10 /pmc/articles/PMC3677136/ /pubmed/23772219 http://dx.doi.org/10.3389/fneur.2013.00064 Text en Copyright © 2013 Sánchez-Ferro, Benito-León and Gómez-Esteban. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Neuroscience Sánchez-Ferro, Álvaro Benito-León, Julián Gómez-Esteban, Juan Carlos The Management of Orthostatic Hypotension in Parkinson’s Disease |
title | The Management of Orthostatic Hypotension in Parkinson’s Disease |
title_full | The Management of Orthostatic Hypotension in Parkinson’s Disease |
title_fullStr | The Management of Orthostatic Hypotension in Parkinson’s Disease |
title_full_unstemmed | The Management of Orthostatic Hypotension in Parkinson’s Disease |
title_short | The Management of Orthostatic Hypotension in Parkinson’s Disease |
title_sort | management of orthostatic hypotension in parkinson’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677136/ https://www.ncbi.nlm.nih.gov/pubmed/23772219 http://dx.doi.org/10.3389/fneur.2013.00064 |
work_keys_str_mv | AT sanchezferroalvaro themanagementoforthostatichypotensioninparkinsonsdisease AT benitoleonjulian themanagementoforthostatichypotensioninparkinsonsdisease AT gomezestebanjuancarlos themanagementoforthostatichypotensioninparkinsonsdisease AT sanchezferroalvaro managementoforthostatichypotensioninparkinsonsdisease AT benitoleonjulian managementoforthostatichypotensioninparkinsonsdisease AT gomezestebanjuancarlos managementoforthostatichypotensioninparkinsonsdisease |